Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
The investigational advanced melanoma combination therapy consisting of RP1 and nivolumab have a PDUFA action date of July 22 ...
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...
Leaders from the WHO responded with a statement saying that the organization hopes the United States will reconsider. “WHO ...
Appearing to stick closely to what was shown on teleprompters to the left and right of the podium with the familiar ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...
A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...
CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback